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Abstract
Context—Individuals experiencing prodromal symptoms of schizophrenia (ultra-high-risk group)
demonstrate impaired performance on tasks of executive function, attention, and working memory.
The neurobiological underpinnings of such executive deficits in ultra-high-risk individuals remains
unclear.
Objective—We assessed frontal and striatal functions during a visual oddball continuous
performance task, in ultra-high-risk, early, and chronic schizophrenic patients with the use of
functional magnetic resonance imaging.
Design—Cross-sectional case-control design.
Setting—Community; outpatient clinic.
Patients—Fifty-two individuals (control, n = 16; ultra-high risk, n = 10; early, n = 15; chronic, n
= 11) from a referred clinical sample and age- and sex-matched control volunteers underwent
scanning.
Main Outcome Measures—Percentage of active voxels and percentage signal change calculated
for the anterior cingulate gyrus (ACG), middle frontal gyrus (MFG), inferior frontal gyrus (IFG),
basal ganglia, and thalamus. Performance on the visual oddball task was measured with percentage
of hits and d′ (a measure based on the hit rate and the false-alarm rate).
Results—The ultra-high-risk group showed significantly smaller differential activation between
task-relevant and task-irrelevant stimuli in the frontal regions (ACG, IFG, MFG) than the control
group. Frontostriatal activation associated with target stimuli in the early and chronic groups was
significantly lower than the control group, while the ultra-high-risk group showed a trend toward the
early group.
Conclusions—Our findings suggest that prefrontal function begins to decline before the onset of
syndromally defined illness and hence may represent a vulnerability marker in assessing the risk of
developing psychotic disorders among ultra-high-risk individuals.
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Schizophrenia is widely considered to be a genetically mediated neurodevelopmental disorder,
1,2 with symptoms typically emerging in late adolescence or early adulthood, followed by a
steady clinical decline throughout life, consistent with a neuroprogressive process. 3 The
prodromal phase preceding the onset of the formal symptoms of schizophrenia includes
positive psychotic symptoms, negative symptoms,4,5 and cognitive deficits that include
distractibility.6 Individuals experiencing prodromal symptoms have a significantly greater
probability of developing the illness,4,6 suggesting that specific aspects of prodromal
symptoms may reflect vulnerability markers for developing schizophrenia.7 However,
prodromal symptoms, which overlap with experiences and behaviors of similar-aged
individuals, many of whom do not develop schizophrenia, are mild and have low predictive
value as vulnerability markers. Therefore, the current behavioral and symptomatic criteria for
the prodromal stage are neither sufficiently sensitive nor specific for reliable early diagnosis
of psychotic disorders. Consequently, there is a critical need for identifying markers that are
more closely tied to neural function and linked to the pathophysiologic mechanisms of
schizophrenia, and therein augment the validity and specificity of clinical features preceding
illness onset.
It is generally accepted that interactions along the frontostriate pathways form the basis for
higher executive functions and the organization, selection, and generation of task-appropriate
thoughts and behaviors.8 It is well established that continuous performance–type tasks such as
the forced choice visual oddball task yield robust activation that localizes brain regions
associated with visual executive processing and selective attention.9–16 Studies in ultra-high-
risk individuals show impaired behavioral performance on continuous performance tasks and
indicate that impaired attention is (1) evident in schizophrenic patients regardless of clinical
state, (2) detectable before illness onset, (3) present in first-degree relatives, and (4) predictive
of later behavioral disturbances in susceptible individuals.17 Deficits on tasks of visual
selective attention, executive function, working memory, and response inhibition18–21 have
been associated with prefrontal functional abnormalities in schizophrenic patients,22–32
beginning as early as the first episode of illness.33 Frontal and striatal regions are thus
prominently implicated in the pathophysiology of schizophrenia, and further show structurally
abnormal neuroanatomic findings.34–37 Evidence of structural abnormality comes from
cytoarchitectural analysis of postmortem patient brains,38,39 neurocellular alterations,40 and
disorganized prefrontal white matter.41,42 Midbrain regions, which provide major afferents to
prefrontal cortical regions, have reduced thalamic volumes43,44 and disrupted subcortical
function in schizophrenia.45,46 Such structural43,44,47–49 and functional13,45,46,50 alterations
in subcortical regions have been associated with deficits in sensory filtering, behavioral control,
and flexibility.
In high-risk adolescents, performance deficits in attention and executive function tasks17 that
are associated with frontostriatal cortical dysfunction and, more recently, findings of decreased
gray matter in inferior frontal cortex and in the cingulate cortex51 have been reported to precede
the clinical expression of illness. These attention impairments are comparable in severity with
impairments observed in adult clinical cases and are the strongest predictors of evolving into
schizophrenia.17 Similarly, first-degree relatives of individuals with schizophrenia and persons
diagnosed as having schizotypal personality disorder display attention and executive function
deficits that are early clinical markers in the diathesis for schizophrenia.52,53 Together, these
findings implicate a functional deficit in brain regions responsible for attention and executive
function during the prodromal stage. Examining frontostriatal dysfunction, associated with the
early and chronic stages of schizophrenia, may lead to the identification of novel vulnerability
markers present during the prodrome of illness. To date, there have been no published
functional magnetic resonance imaging (fMRI) studies in high-risk populations experiencing
prodromal symptoms. The characterization of a postulated neuroprogressive pathologic finding
associated with the onset of schizophrenia motivated our efforts.
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The aims of this study were (1) to use fMRI to examine the functional integrity of frontostriatal
regions in an ultra-high-risk group experiencing prodromal symptoms; (2) to examine the
relationship of frontostriatal function to stage of illness; and (3) to assess specific aspects of
prefrontal deficits related to selective attention and executive function that facilitate goal-
directed behavior through the selection of task-relevant stimuli and filtering of task-irrelevant
novel stimuli. Using a cross-sectional experimental design, we studied 3 groups of patients
(ultra-high-risk, early, and chronic) selected for their stage of illness, and a fourth control group.
We hypothesized that patients in the early and chronic stages would show evidence of
frontostriatal abnormality, reflected in reduced extent and intensity of activation, and that ultra-
high-risk individuals would exhibit milder abnormality of the same form.
METHODS
SUBJECTS
We used imaging data from 52 subjects divided into 4 groups: (1) ultra-high risk (n = 10), (2)
early schizophrenia (n = 15), (3) chronic schizophrenia (n = 11), and (4) control (n = 16). As
expected, the chronic group was significantly older (P<.005), while the other 3 groups were
not significantly different from one another. Because the chronic group was significantly older
than all the other groups, we performed separate analyses to compare an older control group
of 10 subjects (mean age, 34 years) with the chronic group (mean age, 38 years) that did not
show a between-group age difference (P =.35). The mean duration of illness of the chronic
group was significantly longer than that of the early group (P<.001). Demographic and clinical
characteristics of the subject groups are summarized in the Table. Ultra-high-risk patients were
recruited through local media advertisements, whereas patients for the early and chronic groups
were recruited from the University of North Carolina at Chapel Hill and Dorothea Dix State
Psychiatric Hospital, Raleigh, NC.
Diagnoses were confirmed by the Structured Clinical Interview for DSM-IV administered by
University of North Carolina staff psychiatrists and rated by means of the Positive and Negative
Syndrome Scale54 and the Symptom Onset in Schizophrenia inventory.55 None of the patients
was acutely psychotic at the time of testing. Subjects were excluded for past substance
dependence, substance abuse within the past month, and pregnancy. Negative results of urine
toxicology and serum pregnancy tests were confirmed before the fMRI session. Individuals
with a history of psychiatric illness or a first-degree relative having a psychotic illness were
excluded from participating as control subjects. All subjects received a complete verbal
description of the study, and written informed consent was obtained for procedures approved
by the institutional review boards at University of North Carolina at Chapel Hill and Duke
University Medical Center, Durham, NC.
ULTRA-HIGH-RISK PATIENT EVALUATION
Ultra-high-risk subjects were screened by means of the Structured Interview for Prodromal
Symptoms,56 and those who met the clinical criteria defined in the Criteria of Prodromal
Symptoms57 were invited to enter the study. All patients met state criteria, while a subset of
them met both state and trait criteria as summarized in this paragraph. At the time of writing,
2 of the 10 patients had already progressed to schizophrenia and therefore had actually been
prodromal at the time of their fMRI sessions. Of the 10 patients in this group, 2 (not the same
2 who progressed) were taking antipsychotic medication and 4 were taking antidepressant
medication. Briefly, the Criteria of Prodromal Symptoms require that individuals meet at least
one of the following clinical criteria: (1) for brief intermittent psychotic state: psychotic
symptoms emerging in the recent past that occur too briefly to meet official criteria for a
diagnosis of psychosis; (2) for attenuated positive symptom state: nonpsychotic predelusional
unusual thoughts, prehallucinatory perceptual abnormalities, or pre–thought-disordered
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speech disorganization; or (3) for genetic risk and deterioration state: genetic risk for psychosis
(first-degree relative with schizophrenia spectrum disorder and/or schizotypal personality
disorder in proband) plus a recent loss of social and/or work or school capacity equivalent to
a drop in global assessment of function of 30 points sustained for at least 1 month.
STIMULI AND TASK
Participants were presented with visual stimuli from 1 of 3 categories in a semirandomized
sequential manner. Stimuli consisted of frequently occurring (94%) squares of varying size
and color (standards), infrequent (3%) circles of varying size and color (targets), and infrequent
(3%) pictures of everyday objects (novels). All stimuli were presented centrally against a white
background for 500 milliseconds, with a stimulus onset asynchrony of 1500 milliseconds, and
sustained a visual angle of 6°. Each visual stimulus was accompanied by a simultaneously
presented single pure auditory tone, which participants were instructed to ignore, and which
was presented binaurally as part of a separate study of unattended auditory processing. In each
imaging session, subjects performed 7 runs (5 minutes 12 seconds in duration) of this visual
task during which they responded to target stimuli (circles) with a unique button press and
responded to all other stimuli (standard and novel) with an alternate button press. All novels
and targets were separated by at least 9 but not more than 11 visual standards.
ACQUISITION OF fMRI DATA
Images were acquired on a 1.5-T scanner (Signa; General Electric Co, Milwaukee, Wis) with
a birdcage-type standard quadrature head coil and an advanced nuclear magnetic resonance
echoplanar system. The participant’s head was positioned along the canthomeatal line and
immobilized by means of a vacuum cushion and a forehead strap. T1-weighted sagittal scans
were used to select 16 contiguous oblique axial slices parallel to the anterior commissure–
posterior commissure plane, which provided the coplanar anatomic images. Sixteen coplanar
functional images were acquired by means of a gradient echoplanar sequence (repetition time,
1500 milliseconds; echo time, 40 milliseconds; flip angle, 90°; number of signals acquired, 1;
voxel dimensions, 3.75×3.75×5 mm; imaging matrix, 64×64 voxels). Each of the 7 imaging
runs consisted of 200 time points. Four radiofrequency excitations were performed before
image acquisition to achieve steady-state transverse relaxation. Finally, high-resolution T1-
weighted anatomic images (3-dimensional spoiled gradient-recalled imaging; repetition time,
22 milliseconds; echo time, 5 milliseconds; flip angle, 20°; field of view, 24 cm; voxel
dimensions, 0.9375×0.9375×1.5 mm; 256×256 voxels; 124 images) as well as 2-dimensional
spinecho sequence (repetition time, 4000 milliseconds; echo time, 20 milliseconds; flip angle,
90°; field of view, 24 cm; 1.5-mm slice thickness), were acquired for future morphometric and
volumetric analyses.
FUNCTIONAL IMAGE ANALYSIS
All image analyses were performed with custom analysis software written in MATLAB. Head
motion was detected by center-of-mass measurements in 3 orthogonal planes. Six scans were
discarded because of motion and other artifacts, constituting a 10% attrition rate of scanned
subjects. Movement greater than 1mmfrom baseline was used as the rejection criterion for
motion artifact and resulted in the elimination of 1 of 7 runs in 1 control subject, 1 ultra-high-
risk subject, 2 early schizophrenic subjects, and 1 chronic schizophrenic subject, or about 1%
of the total data. To examine the possibility that significant group differences in motion could
be driving observed group differences in activation, we computed the standard deviation of the
center of mass over the time course of each run and then calculated the mean of all included
runs for each subject. These data were computed separately for movement in the x, y, and z
directions. A repeated-measures analysis of variance (ANOVA) was performed with group as
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the “between” factor and the standard deviation in x, y, z as the “within” factor, which failed
to show significant group differences (F3,96=1.6, P=.21).
Following the procedure of McCarthy et al,14 image time segments consisting of 5 images
preceding, 9 images following, and the image coincident with each target presentation were
excised from the functional runs. These segments were then averaged, and the mean of the 5
prestimulus images across all epochs was subtracted from each of the subsequent averaged 10
images to generate baseline-adjusted epochs.
Image analyses were performed with a region-of-interest approach. The following brain
regions of interest were manually traced on the basis of anatomic landmarks on the coplanar
high-resolution anatomic slices measured 5 mm apart traversing superiorly from the anterior
commissure–posterior commissure axial plane: anterior cingulate gyrus (ACG; 5–35 mm),
middle frontal gyrus (MFG; 5–35 mm), inferior frontal gyrus (IFG; 5–30 mm, including pars
opercularis and pars triangularis), basal ganglia (BG; 5 mm), and thalamus (TH; 5–10 mm).
Voxels activated in a task-dependent fashion in response to the 2 stimulus conditions of interest
(visual target and visual novel) were identified within each region of interest by means of a
correlation of the functional segments with the time course of an empirically derived
hemodynamic function.9,14 Voxels with a time course that correlated with the template above
a T value of 1.96 (95% confidence interval) were accepted as active voxels. For each subject,
the average ratio of active voxels to total voxels in each region (ACG, IFG, MFG, BG, and
TH) was computed for each of the task stimulus conditions (targets, novels) and referred to as
the dependent measure of “percentage of active voxels” (PAV). In a similar manner, the average
of percentage signal change for targets and novels relative to a baseline of standards was
computed for all of the above regions and constituted the dependent measure of “percentage
signal change” (PSC). Thus, PSC (representing the magnitude of activation) and PAV
(representing a measure of the extent of activation) served as dependent measures in subsequent
region-of-interest–based statistical analyses. We also used SPM99 (Statistical Parametric
Mapping, 1999 Version) software (Wellcome Department of Cognitive Neurology, London,
England) to normalize individual subject activation maps to a template brain and generate
group-average activation maps.
STATISTICAL ANALYSIS
We hypothesized that, behaviorally, patients would demonstrate poor task-relevant target
discrimination abilities relative to controls, in the absence of a strong generalized response
bias. Behavioral performance analysis was conducted on percentage of hits, d′, and B′′
measures. Our use of d′ (|ZHit−ZFA|), which is based on the hit rate and the false alarm (FA)
rate (incorrect response to standard or novel), was motivated by its power in measuring
discriminability and evidence of its decline in ultra-high-risk and schizophrenia groups. B′′ (y
[1−y]−x[1−x]/y[1−y]+x[1−x], where y equals the probability of hits and x equals the probability
of false alarms), a measure of “response bias,” was calculated as an index of a subject’s
tendency to overrespond or underrespond.
We hypothesized that prefrontal (MFG, IFG), medial frontal (ACG), and striatal (BG, TH)
function, as measured by activation in these regions in response to target stimuli, would be
diminished in all clinical groups (chronic, early, and ultra-high-risk) as compared with the
control group. For prefrontal and striatal regions, our hypothesis was tested by the repeated-
measure ANOVA tested separately on 2 dependent measures of activation (PAV and PSC)
using 1 between factor of group (4 levels) and 1 within factor of region (2 levels for prefrontal
and 2 levels for striatal). The medial frontal analysis used a simple 1-way ANOVA. All post
hoc analyses of ANOVA results were performed at the 5% significance level using the Dunnett
test, a specialized multiple-comparison test that performs fewer comparisons when a collection
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of multiple groups is compared with a single control group. Therefore, all post hoc analysis
performed for this study was corrected for multiple comparisons.
The second hypothesis concerned the differential reduction between the target and novel
response-related activation. Healthy individuals have significantly greater prefrontal activation
to target than to novel stimuli. We hypothesized that the 3 clinical groups would have smaller
differential task-dependent activation than the control group in ACG, IFG, and MFG. The
differential activation was computed by subtracting PAV associated with the novels from PAV
associated with the targets for each subjects in the ACG, IFG, and MFG. This hypothesis was
also tested with a repeated-measures ANOVA using 1 between-factor of group (4 levels) and
1 within-factor of region (3 levels) on the PAV and PSC data.
To further test our hypotheses of decrements in frontal and striatal activation associated with
illness progression, we used nonparametric statistics to perform trend analyses of the 4 groups
by using the Jonckheere-Terpstra (JT) test. The goal of the JT test is to test a null hypothesis
against an alternative of control>ultra-high-risk>early schizophrenia>chronic schizophrenia.
In other words, it was intended to answer the question of whether there is a monotonic trend
among the means of activation in each of the 4 groups. The test is a variation on the Mann-
Whitney test–Wilcoxon rank sum test. The test was performed separately on each region (ACG,
BG, IFG, MFG, and TH) with the use of 1 dependent variable examined across 4 groups. The
quality of trend analysis was reported as z statistic and P value.
RESULTS
CLINICAL MEASURES AND BEHAVIORAL PERFORMANCE
There were significant group differences in behavioral performance as measured by percentage
hits (F3,48=3.4, P=.03) (Figure 1). Post hoc analysis showed that the control group had greater
percentage hits than the early and chronic groups, but not the ultra-high-risk group. Trend
analysis confirmed a highly significant trend of diminishing performance across the 4 groups
(control>ultra-high-risk>early>chronic) of subjects (z=3.9, P<.001). Analysis of d′ excluding
1 outlier in the control group with a high rate of false alarms (>3 SDs from the mean) showed
a significant group difference (F3,47=4.29, P=.01) (Figure 2). Post hoc analysis showed a
significantly higher d′ in the control group than in the ultra-high-risk group and the early
schizophrenia group, and marginally higher than in the chronic group. Trend analysis using
the JT test showed a significant trend (z = 2.9, P=.002). Analysis of B′′ to examine perseverative
behavior or biases did not find significant group differences.
The cognitive subscale of the Positive and Negative Syndrome Scale,54,58 used to examine
cognitive disorganization, disclosed marginally significant differences between the clinical
groups (F2,32=3.3, P=.052). Trend analysis with the JT test demonstrated diminishing cognitive
scores (ultra-high-risk>early>chronic) across the 3 clinical groups (z = 2.6, P=.005).
TARGET VS NOVEL DIFFERENTIAL ACTIVATION
As expected, we found differential frontal (ACG, IFG, MFG) activation (PAV) to target vs
novel stimuli and found a significant main effect of group (F3,48=4.0, P<.02) and of region
(F2,98=12.2, P<.001), but no group×region interaction (Figure 3). Post hoc analysis showed
greater activation in the controls than in the ultra-high-risk, early, and chronic groups and ACG
greater than MFG and IFG activation. This finding suggests that prefrontal deficits associated
with discrimination of task-relevant target stimuli from task-irrelevant novel stimuli are present
in ultra-high-risk individuals experiencing prodromal symptoms of schizophrenia. Older
controls showed greater differential activation than did the chronic group (F1,38=7.7, P=.02).
Analysis using sex as a blocking factor did not show any effects for sex.
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ILLNESS EFFECTS ON FRONTOSTRIATAL FUNCTION
Figure 4 presents decline in target-related activation associated with progression of illness.
Quantitative assessment showed significant differences in prefrontal targetrelated activation
for group (F3,48=4.6, P=.01) and region (F1,48=12.8, P<.001), but no group×region interaction
(Figure 5). Post hoc analysis showed greater extent of activation in controls than in the early
and chronic groups, and in IFG than in MFG. Similarly, in the striatal region there was a
significant difference for group (F3,48=5.6, P=.002), with greater activation in controls than in
the early and chronic groups (Figure 6). These results were consistent with our hypothesis of
diminished frontostriatal activation in the early and chronic groups, but did not find
significantly reduced prefrontal activation in the ultra-high-risk group. In the medial frontal
region, there was a significant difference for group (F3,48=3.5, P=.02) with greater activation
in the control than the chronic group. We compared the chronic group directly with age-
matched older controls and found that the chronic group still showed significantly lower target
vs novel differential activation in the frontal region (F1,38=7.7, P=.02), lower target-associated
medial frontal (F1,19=6.7, P=.02) and prefrontal (F1,19=7.9, P=.02) activation, and marginally
lower striatal (F1,19=4.2, P=.06) activation. The JT trend analysis suggested a significant
difference in extent of activation across the 4 groups (control>high-risk>early>chronic) in all
the regions: ACG (z=3.52, P<.001), BG (z=2.16, P<.02), IFG (z=3.57, P<.001), MFG (z=3.32,
P<.001), and TH (z=3.76, P<.001). Analysis using sex as a blocking factor did not show any
effects for sex.
EXPLORATORY EVALUATION OF LATERALITY EFFECTS
Lateralized structural and functional deficits, ranging from lateralized left hemisphere
deficits59,60 to overall reduced laterality,61 have frequently been reported in schizophrenia.
We performed exploratory analysis of laterality for each of the brain regions and found
differences in target-related activation for group (F3,48=4.2, P=.01), side (F1,48=37.1, P<.001),
and a group×side interaction (F3,49=6.5, P<.001), but only in the IFG (Figure 7). Post hoc
analysis showed that controls had greater right- than left-sided activation as compared with
early and chronic groups,59–62 but not greater than the ultra-high-risk group, reflecting a
reduced laterality for both groups, consistent with previously reported laterality effects.
COMMENT
In summary, our fMRI findings show that the ability to differentially activate frontal brain
regions (ACG, IFG, andMFG)to target vs novel stimuli was significantly lower in individuals
experiencing prodromal symptoms of schizophrenia (ultra-high-risk group) compared with
controls. The activation showed further decrements in groups that represent early and chronic
stages of schizophrenia. This finding suggests regional impairments in circuits responsible for
filtering task-relevant visual information from task-irrelevant but salient visual information.
Our second major finding shows that frontal and striatal activation associated with target
conditions is smaller in the early and chronic patient groups but not significantly lower in the
ultra-high-risk group. However, trend analysis confirms a highly significant declining trend of
activation in frontal and striatal regions across the 4 subject groups (control>ultra-high-
risk>early>chronic) consistent with a neuroprogressive abnormality.35,63–67
BEHAVIORAL PERFORMANCE
Behavioral performance analyses indicated impaired target discrimination (d′) in ultra-high-
risk and early groups relative to the control group. The trend analysis results confirmed a
significant declining performance on discrimination measures in the absence of a significant
difference between groups in overall performance bias, which successfully replicates
behavioral performance studied in continuous performance tasks among ultra-high-risk
individuals.17
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Impaired attention has been related to personality development delays in subjects with a
susceptibility to schizophrenia.68,69 Attention deficits dating back to childhood often lead to
an inability to efficiently process information from the environment, especially subtle and
highly complex interpersonal cues and communications. The long-term impact of chronic
impairments in attention have also been associated with deficient social skills, leading to social
isolation—a key index of negative symptomatology.17,68,70
fMRI MEASURES
The ability to differentially activate to target vs novel stimuli is diminished in individuals
experiencing prodromal symptoms of schizophrenia. This fairly distributed frontal lobe
abnormality is evident in the significant reduction of activation between the control group and
the ultra-high-risk group, and persists in the early and chronic groups. In the absence of disease,
the prefrontal regions (MFG and IFG) are critical in target and novelty detection9,71 and the
medial frontal region (ACG) in decision making and action and conflict monitoring. 11,72 The
inability to process and act on task-relevant sensory inputs while filtering out task-irrelevant
sensory inputs may underlie impairments in executive function and attention that can be
correlated with prefrontal abnormality and, as indicated by our findings, is present in
individuals experiencing prodromal symptoms of schizophrenia. This finding, interpreted as
assigning heightened salience to task-irrelevant stimuli, can be explained by means of perhaps
the most widely adopted theory on the pathophysiology of schizophrenia: the dopamine
hypothesis.73,74 Normally, the stimulus-linked release of dopamine mediates the acquisition
and expression of relevant motivational saliences in response to the subjects’ environment. In
schizophrenia, dysregulated dopamine transmission leads to a stimulus-independent release of
dopamine. This neurochemical change overwhelms the normal process of context-driven
salience attribution and leads to improper assignment of salience to external objects and to
internal representations. Thus dopamine, which in healthy normal conditions is a mediator of
contextually relevant salience, becomes a creator of inappropriate salience in schizophrenia.
75–77 The increased release of dopamine, mismatched with the context, leads to improper
assignment of salience to external stimuli. Indeed, it is plausible that the proposed mechanism
can explain our observed findings as well the clinical phenomenology observed in patients
experiencing prodromal symptoms.75 Therefore, our findings are consistent with outcomes
extrapolated from the dopamine hypothesis and its implications on mesocortical and
mesolimbic dysregulation. The mechanisms for dopamine excess have been variously
explained by theories of γ-aminobutyric acid–ergic interneuron dysfunction, glutamatergic
dysregulation, and interrupted maturational pruning in adolescence.75,78–81
The pattern of results that we have obtained supports our hypothesis of diminished prefrontal
function that progresses with chronicity of illness beginning with the onset of prodromal
symptoms. As predicted, we found significantly greater activation in the control group than in
both the early and the chronic groups in the prefrontal (MFG, IFG), medial frontal (ACG), and
striatal (BG, TH) regions. Although the large differences between the control and ultra-high-
risk groups did not meet conventional significance levels by means of parametric statistics,
nonparametric trend analyses clearly demonstrated a significant stepwise decrement in
prefrontal function across the clinical groups. It is also important to note that our high-risk
subjects represent a heterogeneous sample of individuals who might develop schizophrenia or
other psychiatric disorders, or might spontaneously remit. Therefore, it is likely that a group
composed of strictly prodromal patients, ie, who have subsequently been documented to
progress to schizophrenia, will disclose greater impairments on the outcome measures we
investigated than our ultra-high-risk group did. An expanded sample size in the high-risk group
or a longitudinal study of a confirmed prodromal sample would likely demonstrate a significant
difference in activation.
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Potential limitations of our study deserve consideration. While both the early and chronic
groups were medicated, treatment duration was significantly longer for the chronic group, and
only 2 patients in the ultra-high-risk group were receiving antipsychotic treatment.
Furthermore, unlike controls, a subset of patients within each of the 3 clinical groups was taking
antidepressant medication. While it is difficult to disentangle the possible effect of medication
on task-related brain activation, a recent fMRI study of medication-naive first-episode patients
performing a version of the AX–continuous performance task found diminished task-related
activation in the dorsolateral prefrontal cortex,33 thus questioning the contention of medication-
induced activation differences. Finally, confounding effects of a number of demographic
variables such as age and sex in our study could partially be attributed to recruitment difficulties
associated with the inherent nature of each population group, eg, prodromal patients being
younger or females having typically later onset of psychosis.
Understanding the pathophysiology of the emerging and progressing clinical manifestations is
critical to understanding the pathogenesis of schizophrenia and is likely to inform the
development of preventive therapeutic strategies. Critical events of postnatal brain maturation
of the glutamatergic systems take place in adolescence that coincide with onset of illness and
a period of premorbid vulnerability. Therefore, evidence that early treatment can arrest
neuronal damage has important therapeutic implications in ultra-high-risk patients. Although
this study focuses on deficits in prefrontal and midbrain regions associated with executive
function, a large body of literature has focused on temporal cortical dysfunction and associated
deficits in the auditory modality in schizophrenia. 30 Recent studies have suggested that
temporal cortical deficits in schizophrenia may not emerge until later stages of the disorder.
82 Therefore, the pathophysiology of schizophrenia may affect various cortical circuits with a
different chronology. Tracking the variable times of onset and rates of progression of spatially
and temporally distributed neuropathology associated with schizophrenia will be best
evaluated by longitudinal studies. Our data are limited by the cross-sectional experimental
design. Longitudinal cohort studies that examine cortical and subcortical functions at the
prodromal stage could lead to the discovery of discerning vulnerability markers.
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Performance measured as percentage of correct responses to target stimuli (F3,48=3.4, P<.03).
Bars represent mean values; error bars, standard error.
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Analysis of d′ showing a significant group difference (F3,47=4.29, P<.01). The value of d′ (|
ZHit−ZFA|) is based on the hit rate and the false alarm (FA) rate (incorrect response to standard
or novel). Bars represent mean values; error bars, standard error.
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Differential frontal (anterior cingulate gyrus [ACG], inferior frontal gyrus [IFG], middle frontal
gyrus [MFG]) activation (percentage of active voxels) to target vs novel stimuli with a
significant main effect of group (F3,48=4.0, P=.02) and region (F2,98=12.2, P<.001). Post hoc
analysis showed greater activation in the controls than in ultra-high-risk, early, and chronic
groups and ACG greater than MFG and IFG. Bars represent mean values; error bars, standard
error.
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Group-averaged, target-related prefrontal activation in control, ultra-high-risk, early, and
chronic groups. ACG indicates anterior cingulate gyrus; IFG, inferior frontal gyrus; and MFG,
middle frontal gyrus.
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Prefrontal target-related activation for group (F3,48=4.6, P<.01) and region (F1,48=12.8, P<.
001), with greater activation in controls than early and chronic groups. There was medial frontal
activation for group (F3,48=3.5, P=.02) with greater activation in the control than chronic group.
Bars represent mean values; error bars, standard error. ACG indicates anterior cingulate gyrus;
IFG, interior frontal gyrus; MFb, middle frontal gyrus.
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Striatal target-related activation for group (F3,48=5.6, P=.002) with greater activation in
controls than early and chronic groups. Bars represent mean values; error bars, standard error.
BG indicates basal ganglia; TH, thalamus.
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Left and right inferior frontal gyrus target-related activation for group (F3,48=4.2, P=.01), side
(F1,48=37.1, P<.001), and a group×side interaction (F3,49=6.5, P<.001). Bars represent mean
values; error bars, standard error.
Morey et al. Page 20





































































































































































































































































































































































































































































































































































































































































































































































Arch Gen Psychiatry. Author manuscript; available in PMC 2009 August 26.
